Normal view MARC view ISBD view

Genetic polymorphisms of the dopamine D2 and D3 receptor and neuroleptic drug effects in schizophrenic patients.

Dahmen, N

Genetic polymorphisms of the dopamine D2 and D3 receptor and neuroleptic drug effects in schizophrenic patients. [electronic resource] - Schizophrenia research Apr 2001 - 223-5 p. digital

Publication Type: Clinical Trial; Controlled Clinical Trial; Letter

ISSN: 0920-9964

Standard No.: 10.1016/s0920-9964(99)00147-4 doi

Subjects--Topical Terms:
Adult
Antipsychotic Agents--adverse effects
Female
Gene Frequency--genetics
Humans
Male
Polymorphism, Genetic--genetics
Receptors, Dopamine D2--genetics
Receptors, Dopamine D3
Schizophrenia--drug therapy

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)